
Micrographia Bio combines imaging mass spectrometry and AI to map protein distributions in tissues. Its platform uncovers drug targets and mechanism insights at cellular resolution—accelerating therapeutic development.
Similar startups

Micrographia Bio combines imaging mass spectrometry and AI to map protein distributions in tissues. Its platform uncovers drug targets and mechanism insights at cellular resolution—accelerating therapeutic development.